Validation of novel and accelerated sequences in cranial magnetic resonance imaging
Recruiting
- Conditions
- epilepsyG40Epilepsy
- Registration Number
- DRKS00032397
- Lead Sponsor
- Diagnostische und Interventionelle Neuroradiologie, Uniklinikum Tübingen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Subjects:
-Healthy adults, informed consent.
Patients:
- Informed consent.
-Presence of any of the following criteria: known focal dysplasia, known hippocampal sclerosis, epilepsy without known lesion.
Exclusion Criteria
- MRI Contraindication
- Pregnancy / Lactation
- claustrophobia
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of accelerated sequences in terms of their technical sophistication and information content with respect to the detection of focal cortical dysplasia (FCD) and hippocampal sclerosis (HS)
- Secondary Outcome Measures
Name Time Method - Applicability of the technique in the clinical setting.<br>- How robust are the sequences when used in sick patients with potentially reduced compliance